東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

Coronary artery disease = therapeuti...

Wang, Miao.

FindBook

Google Book

Amazon

博客來

Coronary artery disease = therapeutics and drug discovery /

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	Coronary artery disease/ edited by Miao Wang.
其他題名:	therapeutics and drug discovery /
其他作者:	Wang, Miao.
出版者:	Singapore :Springer Singapore : : 2020.,
面頁冊數:	ix, 339 p. :ill., digital ;24 cm.
內容註:	Coronary Artery Disease: From Mechanism to Clinical Practice -- Evidence in guidelines for treatment of coronary artery disease -- Revascularization For Coronary Artery Disease: Principle And Challenges -- Antithrombotic drugs: pharmacology and perspectives -- Lipid modifying drugs: pharmacology and perspectives -- Anti-hypertensive drugs: pharmacology and perspectives -- Pharmaceutical treatment for Heart failure -- Drug discovery for coronary artery disease.
Contained By:	Springer eBooks
標題:	Coronary heart disease - Treatment. -
電子資源:	https://doi.org/10.1007/978-981-15-2517-9
ISBN:	9789811525179

Coronary artery disease = therapeutics and drug discovery /
Coronary artery diseasetherapeutics and drug discovery /[electronic resource] :edited by Miao Wang. - Singapore :Springer Singapore :2020. - ix, 339 p. :ill., digital ;24 cm. - Advances in experimental medicine and biology,v.11770065-2598 ;. - Advances in experimental medicine and biology ;v.1177..

Coronary Artery Disease: From Mechanism to Clinical Practice -- Evidence in guidelines for treatment of coronary artery disease -- Revascularization For Coronary Artery Disease: Principle And Challenges -- Antithrombotic drugs: pharmacology and perspectives -- Lipid modifying drugs: pharmacology and perspectives -- Anti-hypertensive drugs: pharmacology and perspectives -- Pharmaceutical treatment for Heart failure -- Drug discovery for coronary artery disease.

This book provides an overview of the etiology of coronary artery disease and focuses on the main therapies and drug interventions currently available. It highlights drug pharmacology and therapeutic challenges, with a special emphasis on the underlying principles of available therapeutics and the on-going development of drugs for coronary artery disease. The book is divided into eight chapters, the first of which describes the classical mechanism of coronary artery disease and its clinical presentations. Chapter 2 lists the principles of and related evidence on the prevention and treatment of coronary artery disease. This includes diet and lifestyle management, and guidelines for the treatment of acute coronary syndrome and stable coronary artery disease. In turn, Chapter 3 describes revascularization treatments, covering percutaneous coronary interventions, coronary artery bypass grafts and thrombolysis. This chapter also addresses the main therapeutic challenges. The following chapters provide an overview of three major categories of coronary artery disease drugs, which target thrombosis (Chapter 4), lipid metabolism (Chapter 5), and hypertension (Chapter 6) Heart failure constitutes the major health burden in the late stage of coronary artery disease; accordingly, current heart failure therapeutics and related drug pharmacology are described in Chapter 7. In closing, Chapter 8 provides a summary of on-going clinical trials for coronary artery disease drug development and discusses a number of promising areas in which intensive research into new therapeutics is being pursued. Given its scope, the book will be of interest to clinicians, medical students and research scientists, as well as to pharmaceutical professionals who are seeking new therapies and drugs for coronary artery disease and related disorders.

ISBN: 9789811525179

Standard No.: 10.1007/978-981-15-2517-9doiSubjects--Topical Terms:

559197
Coronary heart disease
--Treatment.

LC Class. No.: RC685.C6 / C676 2020

Dewey Class. No.: 616.12306

Coronary artery disease = therapeutics and drug discovery /
LDR:03377nmm a2200337 a 4500 001 2216767
003 DE-He213
005 20200727150042.0
006 m d
007 cr nn 008maaau
008 201120s2020 si s 0 eng d
020 $a 9789811525179 $q (electronic bk.)
020 $a 9789811525162 $q (paper)
024 7 $a 10.1007/978-981-15-2517-9 $2 doi
035 $a 978-981-15-2517-9
040 $a GP $c GP
041 0 $a eng
050 4 $a RC685.C6 $b C676 2020
072 7 $a MMG $2 bicssc
072 7 $a MED071000 $2 bisacsh
072 7 $a MKG $2 thema
082 0 4 $a 616.12306 $2 23
090 $a RC685.C6 $b C822 2020
245 0 0 $a Coronary artery disease $h [electronic resource] : $b therapeutics and drug discovery / $c edited by Miao Wang.
260 $a Singapore : $b Springer Singapore : $b Imprint: Springer, $c 2020.
300 $a ix, 339 p. : $b ill., digital ; $c 24 cm.
490 1 $a Advances in experimental medicine and biology, $x 0065-2598 ; $v v.1177
505 0 $a Coronary Artery Disease: From Mechanism to Clinical Practice -- Evidence in guidelines for treatment of coronary artery disease -- Revascularization For Coronary Artery Disease: Principle And Challenges -- Antithrombotic drugs: pharmacology and perspectives -- Lipid modifying drugs: pharmacology and perspectives -- Anti-hypertensive drugs: pharmacology and perspectives -- Pharmaceutical treatment for Heart failure -- Drug discovery for coronary artery disease.
520 $a This book provides an overview of the etiology of coronary artery disease and focuses on the main therapies and drug interventions currently available. It highlights drug pharmacology and therapeutic challenges, with a special emphasis on the underlying principles of available therapeutics and the on-going development of drugs for coronary artery disease. The book is divided into eight chapters, the first of which describes the classical mechanism of coronary artery disease and its clinical presentations. Chapter 2 lists the principles of and related evidence on the prevention and treatment of coronary artery disease. This includes diet and lifestyle management, and guidelines for the treatment of acute coronary syndrome and stable coronary artery disease. In turn, Chapter 3 describes revascularization treatments, covering percutaneous coronary interventions, coronary artery bypass grafts and thrombolysis. This chapter also addresses the main therapeutic challenges. The following chapters provide an overview of three major categories of coronary artery disease drugs, which target thrombosis (Chapter 4), lipid metabolism (Chapter 5), and hypertension (Chapter 6) Heart failure constitutes the major health burden in the late stage of coronary artery disease; accordingly, current heart failure therapeutics and related drug pharmacology are described in Chapter 7. In closing, Chapter 8 provides a summary of on-going clinical trials for coronary artery disease drug development and discusses a number of promising areas in which intensive research into new therapeutics is being pursued. Given its scope, the book will be of interest to clinicians, medical students and research scientists, as well as to pharmaceutical professionals who are seeking new therapies and drugs for coronary artery disease and related disorders.
650 0 $a Coronary heart disease $x Treatment. $3 559197
650 1 4 $a Pharmacology/Toxicology. $3 890953
650 2 4 $a Cardiology. $3 861477
650 2 4 $a Pharmacotherapy. $3 1978501
650 2 4 $a Cardiac Surgery. $3 894362
700 1 $a Wang, Miao. $3 1682851
710 2 $a SpringerLink (Online service) $3 836513
773 0 $t Springer eBooks
830 0 $a Advances in experimental medicine and biology ; $v v.1177. $3 3449451
856 4 0 $u https://doi.org/10.1007/978-981-15-2517-9
950 $a Biomedical and Life Sciences (Springer-11642)